Eli Lilly on Thursday reported a home-run quarter fueled by sales of its blockbuster obesity and diabetes drugs, quieting any lingering investor concerns in the stock. Revenue in the second quarter jumped 36% year over year to $11.3 billion, easily topping expectations of $9.92 billion, according to estimates compiled...
Eli Lilly shares are surging after it posted impressive second-quarter results, helped by a combination of more supply and better pricing for its blockbuster weight loss drugs, Mounjaro and Zepbound, suggesting it might be gaining ground against Novo Nordisk . "Investors were nervous going in and this print would...
Under Armour on Thursday said quarterly sales fell 14% in North America, and adjusted its full-year profit guidance after settling a years-old securities lawsuit for $434 million.Still, the company beat Wall Street's expectations on the top and bottom lines.Here's how the athletic apparel company did in its first fiscal...
A general view of a Tim Hortons Drive-Thru coffeehouse and restaurant at Lakeside Retail Park on February 5, 2024 in Grays, United Kingdom.John Keeble | Getty ImagesRestaurant Brands International on Thursday reported quarterly revenue that beat analysts' expectations, fueled by better-than-expected sales at Tim Hortons and the company's international restaurants.Shares...
15 November 2023, Bavaria, Munich: Flags with the word "Siemens" in front of the company's headquarters. Siemens publishes figures for fiscal year 2022/23. Photo: Karl-Josef Hildenbrand/dpa (Photo by Karl-Josef Hildenbrand/picture alliance via Getty Images)Karl-Josef Hildenbrand | Picture Alliance | Getty ImagesGerman industrial technology giant Siemens on Thursday posted better-than-expected...
Kevin Mazur | Getty Images Entertainment | Getty ImagesWarner Bros. Discovery's stock dropped on Wednesday after it reported a $9.1 billion write down on its TV networks and missed analyst estimates on revenue.Here is how Warner Bros. Discovery performed:Loss per share: $4.07. That may not compare with the 22 cent...
Investors want to know whether Eli Lilly is seeing the same pricing pressures on its blockbuster weight loss drug Zepbound that Novo Nordisk experienced with its competing drug Wegovy in the second quarter. Novo Nordisk shocked investors on Wednesday when its latest results fell short of Wall Street's expectations....
Shares of Disney fell Wednesday as concerns about attendance at its theme parks overshadowed streaming profits and better-than-expected headline results. However, the quarter checked the boxes that matter most to us, making the stock decline a buying opportunity. Revenue in the fiscal third quarter totaled $23.16 billion, topping the...
Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Wednesday's key moments. 1. U.S. stocks advanced Wednesday after breaking the market's three-day losing streak in the previous session. The S & P 500 climbed 1.5%, while...
A contractor carries a SunRun solar panel on the roof of a home in San Jose, California, U.S., on Monday, Feb. 7, 2022. David Paul Morris | Bloomberg | Getty ImagesSunrun stock jumped nearly 14% on Wednesday as the rooftop solar installer sees an opportunity to snag market share after...